Table of Contents Author Guidelines Submit a Manuscript
Bioinorganic Chemistry and Applications
Volume 2018, Article ID 7563820, 7 pages
https://doi.org/10.1155/2018/7563820
Research Article

Synthesis, Characterization, and BSA-Binding Studies of Novel Sulfonated Zinc-Triazine Complexes

1Department of Chemistry, University of Sri Jayewardenepura, Nugegoda, Sri Lanka
2Department of Zoology and Environmental Science, University of Colombo, Colombo, Sri Lanka

Correspondence should be addressed to Theshini Perera; kl.ca.pjs@ihseht

Received 18 August 2017; Revised 9 November 2017; Accepted 28 November 2017; Published 18 February 2018

Academic Editor: Francesco Paolo Fanizzi

Copyright © 2018 Nalin Abeydeera et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Fujimoto, H. Yasui, and Y. Yoshikawa, “Development of a novel antidiabetic zinc complex with an organoselenium ligand at the lowest dosage in KK-A(y) mice,” Journal of Inorganic Biochemistry, vol. 121, pp. 10–15, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. N. Poulter, M. Donaldson, G. Mulley et al., “Plasma deposited metal Schiff-base compounds as antimicrobials,” New Journal of Chemistry, vol. 35, no. 7, pp. 1477–1484, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Anbu, S. Kamalraj, B. Varghese, J. Muthumary, and M. Kandaswamy, “A series of oxyimine-based macrocyclic dinuclear zinc(II) complexes enhances phosphate ester hydrolysis, DNA binding, DNA hydrolysis, and lactate dehydrogenase inhibition and induces apoptosis,” Inorganic Chemistry, vol. 51, no. 10, pp. 5580–5592, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. Q. Huang, Z. Pan, P. Wang, Z. Chen, X. Zhang, and H. Xu, “Zinc(II) and copper(II) complexes of β-substituted hydroxylporphyrins as tumor photosensitizers,” Bioorganic and Medicinal Chemistry Letters, vol. 16, no. 11, pp. 3030–3033, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Emami, S. J. Hosseinimehr, S. M. Taghdisi, and S. Akhlaghpoor, “Kojic acid and its manganese and zinc complexes as potential radioprotective agents,” Bioorganic and Medicinal Chemistry Letters, vol. 17, no. 1, pp. 45–48, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. K. V. Thomas, “Determination of the antifouling agent zinc pyrithione in water samples by copper chelate formation and high-performance liquid chromatography–atmospheric pressure chemical ionisation mass spectrometry,” Journal of Chromatography A, vol. 833, no. 1, pp. 105–109, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Aly, A. Gobouri, S. A. Hafez, and H. Saad, “Synthesis, reactions, and biological activity of some triazine derivatives containing sulfa drug moieties,” Russian Journal of Bioorganic Chemistry, vol. 41, no. 4, pp. 437–450, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. J. T. Hunt, T. Mitt, R. Borzilleri et al., “Discovery of the pyrrolo[2,1-f][1,2,4] triazine nucleus as a new kinase inhibitor template,” Journal of Medicinal Chemistry, vol. 47, no. 16, pp. 4054–4059, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. F. Krauth, H.-M. Dahse, H.-H. Rüttinger, and P. Frohberg, “Synthesis and characterization of novel 1,2,4-triazine derivatives with antiproliferative activity,” Bioorganic and Medicinal Chemistry, vol. 18, no. 5, pp. 1816–1821, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. S. K. Pandey, A. Singh, and A. Singh, “Antimicrobial studies of some novel quinazolinones fused with [1,2,4]-triazole, [1,2,4]-triazine and [1,2,4,5]-tetrazine rings,” European Journal of Medicinal Chemistry, vol. 44, no. 3, pp. 1188–1197, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. Z. El-Gendy, J. Morsy, H. Allimony, W. Ali, and R. Abdel-Rahman, “Synthesis of heterobicyclic nitrogen systems bearing the 1,2,4-triazine moiety as anti-HIV and anticancer drugs, Part III,” Die Pharmazie, vol. 56, no. 5, pp. 376–383, 2001. View at Google Scholar
  12. R. Abdel-Rahman, “Chemistry of uncondensed 1,2,4-triazines. Part IV. Synthesis and chemistry of bioactive 3-amino-1,2,4-triazines and related compounds–an overview,” Die Pharmazie, vol. 56, no. 4, pp. 275–286, 2001. View at Google Scholar
  13. Y.-Z. Xiong, F.-E. Chen, J. Balzarini, E. De Clercq, and C. Pannecouque, “Non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 11: structural modulations of diaryltriazines with potent anti-HIV activity,” European Journal of Medicinal Chemistry, vol. 43, no. 6, pp. 1230–1236, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Vzorov, D. Bhattacharyya, L. Marzilli, and R. Compans, “Prevention of HIV-1 infection by platinum triazines,” Antiviral Research, vol. 65, no. 2, pp. 57–67, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. V. Maheshwari, D. Bhattacharyya, F. R. Fronczek, P. A. Marzilli, and L. G. Marzilli, “Chemistry of HIV-1 virucidal Pt complexes having neglected bidentate sp2 N-donor carrier ligands with linked triazine and pyridine rings. synthesis, NMR spectral features, structure, and reaction with guanosine,” Inorganic Chemistry, vol. 45, no. 18, pp. 7182–7190, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Ranasinghe, S. Handunnetti, I. C. Perera, and T. Perera, “Synthesis and characterization of novel rhenium (I) complexes towards potential biological imaging applications,” Chemistry Central Journal, vol. 10, no. 1, p. 71, 2016. View at Publisher · View at Google Scholar · View at Scopus
  17. F. Marandi, A. A. Soudi, A. Morsali, and R. Kempe, “Zinc(II) and cadmium(II) complexes of the 3-(2-Pyridyl)-5,6-diphenyl-1,2,4-triazine (PDPT) ligand, structural studies of [Zn (PDPT) 2Cl (ClO4)] and [Cd (PDPT)2 (NO3)(ClO4)],” Zeitschrift für anorganische und allgemeine Chemie, vol. 631, no. 15, pp. 3070–3073, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. V. Béreau and J. Marrot, “Coordination studies of 5,6-diphenyl-3-(2-pyridyl)-1,2,4-triazine towards Zn2+ cation. Synthesis and characterization by X-ray diffraction and spectroscopic methods,” Comptes Rendus Chimie, vol. 8, no. 6-7, pp. 1087–1092, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Anjomshoa, S.J. Fatemi, M. Torkzadeh-Mahani, and H. Hadadzadeh, “DNA-and BSA-binding studies and anticancer activity against human breast cancer cells (MCF-7) of the zinc (II) complex coordinated by 5,6-diphenyl-3-(2-pyridyl)-1,2,4-triazine,” Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, vol. 127, pp. 511–520, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. O. A. Chaves, V. A. da Silva, C. M. R. Sant’Anna et al., “Binding studies of lophirone B with bovine serum albumin (BSA): combination of spectroscopic and molecular docking techniques,” Journal of Molecular Structure, vol. 1128, pp. 606–611, 2017. View at Publisher · View at Google Scholar · View at Scopus
  21. M. E. Salive, J. Cornoni-Huntley, C. L. Phillips et al., “Serum albumin in older persons: relationship with age and health status,” Journal of Clinical Epidemiology, vol. 45, no. 3, pp. 213–221, 1992. View at Publisher · View at Google Scholar · View at Scopus
  22. B. Machura, A. Świtlicka, R. Kruszynski, J. Mroziński, J. Kłak, and J. Kusz, “Coordination studies of 5,6-diphenyl-3-(2-pyridyl)-1,2,4-triazine towards Cu2+ cation. X-ray studies, spectroscopic characterization and DFT calculations,” Polyhedron, vol. 27, no. 13, pp. 2959–2967, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. T. S. Teets, D. V. Partyka, J. B. Updegraff III, and T. G. Gray, “Homoleptic, four-coordinate azadipyrromethene complexes of d10 zinc and mercury,” Inorganic Chemistry, vol. 47, no. 7, pp. 2338–2346, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. F. Kratz, “Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles,” Journal of Controlled Release, vol. 132, no. 3, pp. 171–183, 2008. View at Publisher · View at Google Scholar · View at Scopus